All Journals > Infection Control and Hospital Epidemiology > November 2006 > S. aureus Bacteremia in Elderly Patients

Article Tools

Search for Related Articles

Highlighted Article

NHSN Annual Update:
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections

Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

Antimicrobial-resistant pathogens that cause healthcare-associated infections (HAIs) pose an ongoing and increasing challenge to hospitals, both in the clinical treatment of patients and in the prevention of the cross-transmission of these problematic pathogens.  Describing the magnitude of the problem with respect to these antimicrobial-resistant pathogens is challenging, because the levels of antimicrobial resistance vary for different types of healthcare facilities and for different geographic areas, and some resistance phenotypes are difficult for laboratories to detect. However, the findings from such attempts may help the infection control and public health communities target problems and utilize resources more efficiently.

In the News

Featured in The Times
"Ireland 'losing war' on superbug" February 15, 2009
Challenges of Implementing National Guidelines for the Control and Prevention of Methicillin‐Resistant Staphylococcus aureus Colonization or Infection in Acute Care Hospitals in the Republic of Ireland
Fidelma Fitzpatrick, MD; Fiona Roche, PhD; Robert Cunney, MB; Hilary Humphreys, MD; Strategy for the Control of Antimicrobial Resistance in Ireland Infection Control Subcommittee
The research, published in Infection Control and Hospital Epidemiology, found one third of hospitals did not have a written policy on antibiotic use, and only 35% had an antibiotic stewardship programme.

November 2006

Volume 27, Number 11
Infect Control Hosp Epidemiol 2006;27:1219–1225
0899-823X/2006/2711-0013$15.00
DOI: 10.1086/507924
Original Article

Staphylococcus aureus Bacteremia in Older Adults: Predictors of 7‐Day Mortality and Infection With a Methicillin‐Resistant Strain

Mazen S. Bader, MD, MPH

From the Division of Geriatric Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. (Present affiliation: the Division of Microbiology and Infectious Diseases, Memorial University of Newfoundland Health Sciences Center, St. John’s, Newfoundland, Canada.)

Objectives.To determine the predictors of 7‐day mortality in older adult patients with Staphylococcus aureus bacteremia after controlling for comorbidity using the Charlson weighted index of comorbidity (WIC) and to identify the risk factors associated with bacteremia due to methicillin‐resistant S. aureus (MRSA).

Design.Retrospective cohort study from January 2003 until December 2004.

Setting.Two tertiary care, university‐affiliated hospitals.

Methods.One hundred thirty‐five hospitalized patients with S. aureus bacteremia were included in the study. All patients who were 60 years or older and had 1 or more blood cultures positive for S. aureus were included in the study. The primary outcome was death 7 days after the onset of S. aureus bacteremia.

Results.Twenty‐one patients (15.6%) died within 7 days after the onset of S. aureus bacteremia. Seventy‐four patients (56.1%) had MRSA bacteremia. Multivariate analysis identified 3 independent determinants of 7‐day mortality: Charlson WIC score greater than 5 (odds ratio [OR], 3.6 [95% confidence interval {CI}, 1.1‐11.2]; ), previous hospitalization in the past 3 months (OR, 5.0 [95% CI, 1.1‐25.1]; ), and altered mental status at the onset of S. aureus bacteremia (OR, 13.6 [95% CI, 2.9‐64.6]; ). Multivariate analysis identified previous hospitalization in the past 3 months (OR, 2.6 [95% CI, 1.1‐5.9]; ), residence in a long‐term care facility (OR, 4.5 [95% CI, 1.7‐12.3]; ), and altered mental status at the onset of S. aureus bacteremia (OR, 2.5 [95% CI, 1.5‐5.6]; ) to be independently associated with the presence of MRSA.

Conclusions.The Charlson WIC is significantly associated with increased mortality of S. aureus bacteremia in older adults. Previous hospitalization in the past 3 months, residence in a long‐term care facility, and altered mental status should be used as a guidance for empirical vancomycin therapy and application of infection control measures in older adults with suspected S. aureus bacteremia.

Received August 26, 2005; accepted December 16, 2005; electronically published September 29, 2006.

Address reprint requests to Mazen S. Bader, MD, MPH, Memorial University of Newfoundland Health Sciences Center, Division of Microbiology and Infectious Diseases, 300 Prince Phillip Drive, Office 1J426, St. John’s, Newfoundland A1B3V6, Canada ().

Cited by

Robert E. Burke, MD; Meira S. Halpern, PhD; Ellen Jo Baron, PhD, D(ABMM); Kathleen Gutierrez, MD. (2009) Pediatric and Neonatal Staphylococcus aureus Bacteremia: Epidemiology, Risk Factors, and Outcome •. Infection Control and Hospital Epidemiology 30:7, 636-644
Online publication date: 1-Jul-2009.
F. K. Gould, R. Brindle, P. R. Chadwick, A. P. Fraise, S. Hill, D. Nathwani, G. L. Ridgway, M. J. Spry, R. E. Warren, . (2009) Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. Journal of Antimicrobial Chemotherapy 63:5, 849-861
Online publication date: 5-Apr-2009.
CrossRef
Mary D. Barakzai, Dorothy Fraser. (2008) Assessment of Infection in Older Adults. Journal of Gerontological Nursing 34:1, 7-12
Online publication date: 1-Feb-2008.
CrossRef
Ilker Uçkay, Stephan Harbarth, Didier Pittet. (2008) Management of Gram-positive bacteraemia. Current Opinion in Infectious Diseases 20:6, 561-567
Online publication date: 1-Jan-2008.
CrossRef
Evelina Tacconelli, Maria A Cataldo. (2007) Antimicrobial therapy of Staphylococcus aureus bloodstream infection. Expert Opinion on Pharmacotherapy 8:15, 2505-2518
Online publication date: 1-Nov-2007.
CrossRef
Close Popup